« Previous
Next »
Titles
- Racial disparities in COVID-19 experiences among older adults with disabling conditions1
- Racial, ethnic, and language concordance between patients and their usual health care providers1
- Rare diseases: considerations for the development of drugs and biological products : guidance for industry1
- Rate regulation revisited: managing regulatory failure and regulatory capture in health care1
- Rates of anxiety and depression symptoms declined in 2021, remained higher than pre-pandemic1
- Real-time oncology review (RTOR): guidance for industry1
- Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry1
- Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry1
- Recommendations for programs and funders who serve people who use substances: disrupting structural racism’s impact on health and well-being1
- Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components1
- Recommendations to reduce the risk of transfusion-transmitted malaria: guidance for industry1
- Reconditioning of fish and fishery products by segregation1
- Reducing Medicare’s payment rates for intermittent urinary catheters can save the program and beneficiaries millions of dollars each year1
- Reducing microbial food safety hazards in the production of seed for sprouting: guidance for industry1
- Reductions in deaths and hospitalizations associated with COVID-19 vaccinations among Medicare beneficiaries: full year 2021 estimates2
- Referencing the definition of “device” in the Federal Food, Drug, and Cosmetic Act in guidance, regulatory documents, communications, and other public documents: guidance for industry and Food and Drug Administration staff1
- Reformulating drug products that contain carbomers manufactured with benzene: guidance for industry1
- Refusal of inspection by a foreign food establishment or foreign government: guidance for industry1
- Regenerative medicine and advanced therapies: information on workforce and education : report to congressional committees1
- Regenerative medicine. Therapeutic applications, challenges, and policy options1